Non-lymphopenic pneumocystis pneumonia in low-dose methotrexate therapy: An exception to every rule

Pneumocystis jiroveci associated pneumonia (PCP) is one of the most important opportunistic conditions affecting immunocompromised patients, especially those with rheumatic diseases, often associated with lymphopenia and high serum LDH levels. The risk of PCP correlates with immunomodulators' d...

Descripción completa

Detalles Bibliográficos
Autores principales: Lourenço, Jorge, Carreira, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677122/
https://www.ncbi.nlm.nih.gov/pubmed/33251106
http://dx.doi.org/10.1016/j.rmcr.2020.101289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677122/
https://www.ncbi.nlm.nih.gov/pubmed/33251106
http://dx.doi.org/10.1016/j.rmcr.2020.101289

Ejemplares similares